title: [Fulminant acute heart failure following intravenous bolus administration of verapamil in a patient with supraventricular tachycardia].
abstract: Verapamil administered intravenously is recommended as a first-line therapy in patients with supraventricular tachycardia. However, these patients may suffer from tachycardia-induced heart failure and particular caution is needed before prescription of verapamil in these cases. We present a case of fulminant acute heart failure following intravenous bolus administration of verapamil in a previously healthy young man. This case stresses the potential deleterious effects of this commonly prescribed drug.
authors.affiliation: Hjertemedicinsk Afdeling B, Aarhus Universitetshospital, Brendstrupgårdsvej 100, 8200 Aarhus N, Denmark. carsten.stengaard@ki.au.dk
authors.forename: Carsten
authors.initials: C
authors.lastname: Stengaard
authors.forename: Hans
authors.initials: H
authors.lastname: Eiskjær
authors.forename: Henrik Kjærulf
authors.initials: HK
authors.lastname: Jensen
mesh_terms: D061605:Administration, Intravenous; D000328:Adult; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D006333:Heart Failure / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D008297:Male; D013617:Tachycardia, Supraventricular / Q000188:drug therapy; D016896:Treatment Outcome; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D014700:Verapamil